TNGX
Tango Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$21.74
−7.45%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 559.46x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 3.58x
- Price / sales
- 68.12x
- Price / cash flow
- -25.47x
Enterprise value
- Enterprise value
- $2.7B
- EV / sales
- 49.87x
- EV / EBITDA
- -21.95x
- EV / EBIT
- -19.68x
- Market cap
- $3.7B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026